Table 1.
CHR | POS | Ref/Alt | Gene | MAF | Trait | Effect | SE | P-value | Clinvar var. ID | Protein change | Molecular consequence | Condition | Class |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 55,523,798 | A/G | PCSK9 | 0.0032 | LDL | −0.2933 | 0.0364 | 7.26E-16 | 630597 | I424V | Missense | Familial hypercholesterolemias | Benign |
TC | −0.2642 | 0.0358 | 1.69E-13 | ||||||||||
1 | 155,261,697 | G/A | PKLR | 0.0055 | TG | 0.1489 | 0.0277 | 7.58E-08 | 292806 | R490W | Missense | Pyruvate kinase deficiency of red cells | Uncertain significance |
1 | 155,263,025 | A/G | PKLR | 0.0019 | HbA1c | −0.4154 | 0.074 | 1.97E-08 | 225440 | V460A | Missense | Pyruvate kinase deficiency of red cells | Uncertain significance |
2 | 21,228,437 | A/G | APOB | 0.001 | LDL | −0.8857 | 0.0657 | 1.97E-41 | 630249 | I3768T | Missense | Familial hypercholesterolemias | Uncertain significance |
TC | −0.7885 | 0.0651 | 1.00E-33 | ||||||||||
2 | 44,050,063 | G/A | ABCG5 | 0.0012 | LDL | 0.4076 | 0.0594 | 6.80E-12 | 30485 | R446* | Nonsense | Sitosterolemia | Pathogenic |
TC | 0.3758 | 0.0588 | 1.63E-10 | ||||||||||
2 | 44,100,999 | A/G | ABCG8 | 0.0074 | LDL | 0.1784 | 0.0241 | 1.25E-13 | 499929 | M429V | Missense | – | Uncertain significance |
TC | 0.1518 | 0.0238 | 1.81E-10 | ||||||||||
2 | 44,116,923 | C/T | LRPPRC | 0.0091 | LDL | 0.1261 | 0.0217 | 6.07E-09 | 746339 | A1360T | Missense | – | Benign |
9 | 107,560,803 | C/T | ABCA1 | 0.0076 | HDL | −0.1447 | 0.0235 | 7.50E-10 | 364396 | V1674I | Missense | Tangier disease, Familial High Density Lipoprotein Deficiency | Benign |
TC | −0.1317 | 0.0235 | 2.14E-08 | ||||||||||
9 | 107,584,945 | C/A | ABCA1 | 0.0061 | HDL | −0.2315 | 0.0266 | 3.64E-18 | 225290 | C887F | Missense | Familial hypercholesterolemia 1 | Uncertain significance |
TC | −0.1815 | 0.0265 | 7.96E-12 | ||||||||||
10 | 101,165,607 | T/C | GPT | 0.0032 | AST | −0.2246 | 0.04 | 1.90E-08 | 709106 | E183G | Missense | – | Benign |
11 | 116,701,560 | G/A | APOC3 | 0.0008 | HDL | 0.8077 | 0.0755 | 1.02E-26 | 139561 | A43T | Missense | Apolipoprotein C-III deficiency, Coronary heart disease | Pathogenic |
TG | −0.8409 | 0.0761 | 2.39E-28 | ||||||||||
11 | 116,703,580 | A/G | APOC3 | 0.0017 | TG | −0.3203 | 0.0492 | 7.73E-11 | 17902 | T74A | Missense | Apolipoprotein c-iii, nonglycosylated | Pathogenic |
15 | 43,507,389 | C/T | EPB42 | 0.0028 | HbA1c | −0.3386 | 0.0587 | 7.88E-09 | 13233 | A142T | Missense | Spherocytosis type 5 | Pathogenic |
16 | 56,917,997 | C/T | SLC12A3 | 0.0022 | HDL | 0.2593 | 0.0443 | 4.97E-09 | 225468 | A569V | Missense | Familial hypokalemia-hypomagnesemia | Uncertain significance |
16 | 56,918,023 | G/A | SLC12A3 | 0.0047 | HDL | −0.1608 | 0.0297 | 5.91E-08 | 225469 | V578M | Missense | Familial hypokalemia-hypomagnesemia | Benign |
16 | 57,016,150 | G/A | CETP | 0.0005 | HDL | 1.3379 | 0.0877 | 1.60E-52 | 17524 | - | Splice donor | Hyperalphalipoproteinemia 1 | Pathogenic |
17 | 41,246,724 | C/T | BRCA1 | 0.0023 | TG | 0.3234 | 0.0429 | 4.72E-14 | 55726 | G275D | Missense | Breast-ovarian cancer, familial 1, Hereditary cancer-predisposing syndrome, Neoplasm of the breast, AllHighlyPenetrant | Benign |
19 | 11,217,315 | C/T | LDLR | 0.0002 | LDL | 1.0777 | 0.1429 | 4.59E-14 | 251446 | R257W | Missense | Familial hypercholesterolemia | Conflicting interpretation |
TC | 0.9784 | 0.1374 | 1.07E-12 | ||||||||||
19 | 11,227,576 | C/T | LDLR | 0.0002 | LDL | 1.5104 | 0.1428 | 3.80E-26 | 200921 | H583Y | Missense | Familial hypercholesterolemia | Conflicting interpretation |
TC | 1.2383 | 0.1428 | 4.29E-18 | ||||||||||
19 | 11,241,988 | C/T | LDLR | 0.0014 | LDL | −0.3384 | 0.0607 | 2.49E-08 | 374957 | A860V | Missense | Familial hypercholesterolemia | Benign |
19 | 45,207,444 | C/T | CEACAM16 | 0.009 | LDL | −0.1694 | 0.0219 | 1.02E-14 | 226509 | S180F | Missense | – | Benign |
20 | 43,042,364 | C/T | HNF4A | 0.0084 | HDL | −0.1451 | 0.0228 | 2.07E-10 | 129240 | T114I | Missense | Maturity onset diabetes mellitus in young, Hyperinsulinism, Mongenic diabetes | Benign |
Chromosomal positions are based hg19. Effect size is based on alternative allele. ClinVar database was assessed at 1st May 2020. From the conditional analysis results, attenuated rare variants are bold-faced.
CHR chromosome, POS position, MAF minor allele frequency.